Novartis AG (ADR) (NYSE:NVS) said it presented some of the interesting findings from its LBH589 related Phase III clinical study, at the ASCO (American Society of Clinical Oncology) Annual Meeting in Chicago. The company reported that the drug under trial significantly improved the length of survival in patients with bone marrow cancer. Novartis AG (ADR) (NYSE:NVS) net profit margin is 16.50% and weekly performance is -0.74%. On last trading day company shares ended up $89.86. Analysts mean target price for the company is $91.44. Novartis AG (ADR) (NYSE:NVS) distance from 50-day simple moving average (SMA50) is 2.74%.
On 11 JUNE Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) reported $1.22 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.22. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $5.11 million. During the same quarter last year, the company posted $1.12 earnings per share. Teva Pharmaceutical Industries Ltd’s revenue was up 2.0% compared to the same quarter last year. On average, analysts predict that Teva Pharmaceutical Industries Ltd will post $4.74 earnings per share for the current fiscal year. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) shares fell -0.48% in last trading session and ended the day on $51.45. TEVA Gross Margin is 53.00% and its return on assets is 2.90%. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) quarterly performance is 3.81%.
On 22 MAY Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported $0.58 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.94 by $0.36. The company had revenue of $626.00 million for the quarter, compared to the consensus estimate of $609.04 million. During the same quarter in the prior year, the company posted $1.78 earnings per share. The company’s quarterly revenue was up 42.3% on a year-over-year basis. Analysts expect that Regeneron Pharmaceuticals will post $9.83 EPS for the current fiscal year. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) shares moved down -1.87% in last trading session and was closed at $302.62, while trading in range of $302.50 – $309.31. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) year to date (YTD) performance is 9.95%.
Bayer AG (ADR) (OTCMKTS: BAYRY) ended the last trading day at $140.15.
BASF SE (ADR) (OTCMKTS: BASFY) on last trading day company shares ended up $116.77.